Tykhe Corp
Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
Market Cap & Net Worth: Tykhe Corp (HALB)
Tykhe Corp (PINK:HALB) has a market capitalization of $1.49 Million ($1.49 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #50626 globally and #15479 in its home market, demonstrating a -19.23% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Tykhe Corp's stock price $0.00 by its total outstanding shares 707303413 (707.30 Million).
Tykhe Corp Market Cap History: 2015 to 2025
Tykhe Corp's market capitalization history from 2015 to 2025. Data shows growth from $141.46K to $1.49 Million (22.84% CAGR).
Tykhe Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Tykhe Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2761.24x
Tykhe Corp's market cap is 2761.24 times its annual revenue
1728.56x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $990.22K | $164.48K | $5.98K | 6.02x | 165.59x |
| 2017 | $778.03K | $151.22K | -$373.00K | 5.14x | N/A |
| 2021 | $10.96 Million | $5.24K | -$861.54K | 2093.01x | N/A |
| 2022 | $4.10 Million | $8.02K | -$1.62 Million | 511.52x | N/A |
| 2023 | $3.47 Million | $2.73K | -$454.07K | 1271.85x | N/A |
| 2024 | $2.76 Million | $999.00 | -$79.68K | 2761.24x | N/A |
Competitor Companies of HALB by Market Capitalization
Companies near Tykhe Corp in the global market cap rankings as of March 18, 2026.
Key companies related to Tykhe Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Tykhe Corp Historical Marketcap From 2015 to 2025
Between 2015 and today, Tykhe Corp's market cap moved from $141.46K to $ 1.49 Million, with a yearly change of 22.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.49 Million | -46.15% |
| 2024 | $2.76 Million | -20.41% |
| 2023 | $3.47 Million | -15.52% |
| 2022 | $4.10 Million | -62.58% |
| 2021 | $10.96 Million | -37.25% |
| 2020 | $17.47 Million | +1800.00% |
| 2019 | $919.49K | -31.58% |
| 2018 | $1.34 Million | +72.73% |
| 2017 | $778.03K | -21.43% |
| 2016 | $990.22K | +600.00% |
| 2015 | $141.46K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Tykhe Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.49 Million USD |
| MoneyControl | $1.49 Million USD |
| MarketWatch | $1.49 Million USD |
| marketcap.company | $1.49 Million USD |
| Reuters | $1.49 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.